Skip to main content
305 search results for:

Axial spondyloarthritis 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 19-05-2021 | Axial spondyloarthritis | News | Article

    Researchers explore reasons for axial spondyloarthritis diagnostic delays

    The average wait for an axial spondyloarthritis diagnosis is more than 7 years, but the delay varies across Europe and is higher for women and people who develop symptoms at a younger age, real-world study findings indicate.

  2. 17-11-2020 | Axial spondyloarthritis | News | Article

    Mixed results for prednisolone in axial spondyloarthritis

    Treatment with oral prednisolone on a step-down regimen may reduce disease activity in people with axial spondyloarthritis but has minimal impact on other outcomes such as functional improvement, Indian researchers report.

  3. 02-11-2020 | Axial spondyloarthritis | News | Article

    Nurse-led education program could improve axial spondyloarthritis disease management

    Patients with axial spondyloarthritis are likely to derive short-term benefits from a nurse-led education program focused on self-management and self-assessment of disease activity, COMEDSPA trial results suggest.

  4. 08-06-2020 | EULAR 2020 | Conference coverage | Article
    News in brief

    Sustained benefits with secukinumab in nonradiographic axial spondyloarthritis

    The IL-17A inhibitor secukinumab provides significant and sustained improvements in patients with nonradiographic axial spondyloarthritis, indicate 52-week data from the phase 3 PREVENT study.

  5. 05-03-2020 | Axial spondyloarthritis | News | Article

    TNF inhibitors may improve functional status in axial spondyloarthritis

    TNF inhibitors improve the functional status of patients with axial spondyloarthritis, with the degree of improvement in line with disease duration and activity, real-world data suggest.

  6. 19-06-2019 | Axial spondyloarthritis | EULAR 2019 | Article
    News in brief

    Brodalumab shows axial spondyloarthritis treatment potential

    Brodalumab has demonstrated efficacy and appears tolerable for the treatment of axial spondyloarthritis, delegates were told at the EULAR 2019 congress in Madrid, Spain .

  7. 11-10-2019 | Axial spondyloarthritis | Highlight | Teaser
    Expert Opinion: Editorial

    Do current therapies slow radiographic progression in axial spondyloarthritis/ ankylosing spondylitis?

    Preston Le, Stephanie Qi, and Liron Caplan discuss the efficacy of current therapies in slowing radiographic progression of ankylosing spondylitis.

  8. 11-10-2019 | Axial spondyloarthritis | Editorial | Article

    Do current therapies slow radiographic progression in axial spondyloarthritis/ ankylosing spondylitis?

    Preston Le, Stephanie Qi, and Liron Caplan discuss the efficacy of current therapies in slowing radiographic progression of ankylosing spondylitis.

  9. 02-04-2018 | Ankylosing spondylitis | Review | Article

    Personalized axial spondyloarthritis care

    Purpose of review: To discuss the personalized care of patients with axial spondyloarthritis

  10. 21-06-2018 | Axial spondyloarthritis | Review | Article

    Better quantification of syndesmophyte growth in axial spondyloarthritis

    Purpose of review: We review new insights to syndesmophyte growth in axial spondyloarthritis revealed by computed tomography (CT).

  11. 27-07-2018 | Axial spondyloarthritis | Article

    Widespread pain in axial spondyloarthritis: Clinical importance and gender differences

    The aim of this study was to explore the value of a more detailed pain area assessment as an adjunct to axial and peripheral articular pain intensity

  12. 12-05-2018 | Axial spondyloarthritis | Review | Article

    Gender differences in axial spondyloarthritis: Women are not so lucky

    Purpose of Review: Ankylosing spondylitis (AS) was historically seen as a predominantly male disease.

  13. 07-11-2017 | Axial spondyloarthritis | Image

    Axial spondyloarthritis: A diagnostic guide [Title slide]

  14. 21-08-2018 | Axial spondyloarthritis | Review | Article

    Radiologic approach to axial spondyloarthritis: Where are we now and where are we heading?

    The aim of this review was to summarize current recommendations concerning the use of imaging techniques in diagnostics and monitoring of axial

  15. 21-06-2018 | Axial spondyloarthritis | Article

    High reproducibility of an automated measurement of mobility for patients with axial spondyloarthritis

    Garrido-Castro JL et al. J Rheumatol 2018. doi: 10.3899/jrheum.170941

  16. 22-10-2019 | Teaser
    ACR/ARP 2019 clinical trial recommendation

    Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis Following 1 Year of Treatment with Certolizumab Pegol: 48-Week Interim Results from a 96-Week Open-Label Study

    Sunday,   November 10, 17:00–17:15. Georgia World Congress Center, Atlanta, USA Presenting author:  Irene van der Horst-Bruinsma, Netherlands TRIAL RESULTS PUBLISHED  | Read the full story What our Advisory Board said: This is an important analysis for those treating resistant uveitis where certolizumab may have shown efficacy. – Laura Coates, UK

  17. 19-07-2017 | Spondyloarthropathies | News | Article

    Updated treatment targets for axial and peripheral spondyloarthritis

    An international taskforce has developed updated recommendations on therapeutic targets for spondyloarthritis in light of evidence from the past 5 years. Read the linked commentary from Oliver FitzGerald

  18. 23-01-2018 | Axial spondyloarthritis | News | Article

    Imaging results support long-term efficacy of certolizumab pegol for axial spondyloarthritis

    Patients with axial spondyloarthritis who are treated with certolizumab pegol experience a sustained reduction in spinal inflammation, follow-up imaging results from the RAPID-axSpA trial suggest.

  19. 22-05-2017 | Axial spondyloarthritis | News | Article

    Certolizumab efficacy for axial spondyloarthritis sustained over 4 years

    The benefits of certolizumab pegol treatment in patients with axial spondyloarthritis are maintained over 4 years without worsening tolerability, researchers report.

  20. 01-06-2018 | Spondyloarthropathies | Article

    Measurement properties of the ASAS Health Index: Results of a global study in patients with axial and peripheral spondyloarthritis

    Kiltz U et al Ann Rheum Dis 2018. doi: 10.1136/annrheumdis-2017-212076

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.